{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:45:23Z","timestamp":1793245523439,"version":"4.5.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In human follicular lymphoma the t(14; 18) chromosome translocation activates the antiapoptotic oncogene Bcl2 by linking it to the immunoglobulin heavy chain (IGH) locus. Transgenic mice expressing Bcl2 controlled by an Igh enhancer (E\u03bc) do not develop follicular lymphoma, although they do have an increased incidence of other B-lymphoid neoplasms. We have now analyzed tumorigenesis in mice bearing a Bcl2 transgene controlled by Vav gene regulatory sequences (VavP), which confer expression in multiple hematopoietic lineages. Unlike E\u03bc-Bcl2 mice, many VavP-Bcl2 mice older than 10 months developed follicular lymphoma. Young VavP-Bcl2 mice had an overabundance of enlarged germinal centers and greatly elevated numbers of cycling B cells that had undergone IgH class switching and V-gene hypermutation. The peripheral T-cell compartment was larger in the VavP-Bcl2 mice than in E\u03bc-Bcl2 strains and, notably, CD4 T cells were 5-fold increased over normal. The germinal center hyperplasia required CD4 T cells, because it could be abolished by anti-CD4 antibody in vivo. VavP-Bcl2 mice also had a propensity to develop kidney disease of the autoimmune type. We suggest that the increased survival capacity of B and T cells fosters prolonged germinal center reactions, and that autoreactivity and hypermutation conspire to generate follicular lymphoma.<\/jats:p>","DOI":"10.1182\/blood-2003-07-2469","type":"journal-article","created":{"date-parts":[[2003,11,25]],"date-time":"2003-11-25T01:14:27Z","timestamp":1069722867000},"page":"2276-2283","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":207,"title":["VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia"],"prefix":"10.1182","volume":"103","author":[{"given":"Alexander","family":"Egle","sequence":"first","affiliation":[{"name":"From the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Harris","sequence":"additional","affiliation":[{"name":"From the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Bath","sequence":"additional","affiliation":[{"name":"From the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"From the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Cory","sequence":"additional","affiliation":[{"name":"From the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223021723500_REF1","doi-asserted-by":"crossref","unstructured":"Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226: 1097-1099.","DOI":"10.1126\/science.6093263"},{"key":"2020021223021723500_REF2","doi-asserted-by":"crossref","unstructured":"Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 1985;41: 899-906.","DOI":"10.1016\/S0092-8674(85)80070-2"},{"key":"2020021223021723500_REF3","doi-asserted-by":"crossref","unstructured":"Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2\/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986;47: 19-28.","DOI":"10.1016\/0092-8674(86)90362-4"},{"key":"2020021223021723500_REF4","doi-asserted-by":"crossref","unstructured":"Ladanyi M, Wang S. Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis. Diagn Mol Pathol.1992;1: 31-35.","DOI":"10.1097\/00019606-199203000-00005"},{"key":"2020021223021723500_REF5","doi-asserted-by":"crossref","unstructured":"Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335: 440-442.","DOI":"10.1038\/335440a0"},{"key":"2020021223021723500_REF6","doi-asserted-by":"crossref","unstructured":"McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989;57: 79-88.","DOI":"10.1016\/0092-8674(89)90174-8"},{"key":"2020021223021723500_REF7","doi-asserted-by":"crossref","unstructured":"Strasser A, Harris AW, Vaux DL, et al. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol.1990;166: 175-181.","DOI":"10.1007\/978-3-642-75889-8_22"},{"key":"2020021223021723500_REF8","doi-asserted-by":"crossref","unstructured":"McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 1991;349: 254-256.","DOI":"10.1038\/349254a0"},{"key":"2020021223021723500_REF9","unstructured":"Strasser A, Harris AW, Cory S. E\u03bc-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene. 1993;8: 1-9."},{"key":"2020021223021723500_REF10","doi-asserted-by":"crossref","unstructured":"Liu Y, Hernandez AM, Shibata D, Cortopassi GA. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A.1994;91: 8910-8914.","DOI":"10.1073\/pnas.91.19.8910"},{"key":"2020021223021723500_REF11","doi-asserted-by":"crossref","unstructured":"Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 1995;85: 2528-2536.","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528"},{"key":"2020021223021723500_REF12","doi-asserted-by":"crossref","unstructured":"Husson H, Carideo EG, Neuberg D, et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood. 2002;99: 282-289.","DOI":"10.1182\/blood.V99.1.282"},{"key":"2020021223021723500_REF13","doi-asserted-by":"crossref","unstructured":"Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A.1999;96: 14943-14948.","DOI":"10.1073\/pnas.96.26.14943"},{"key":"2020021223021723500_REF14","unstructured":"Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Transplantation. 2000;70: 168-174."},{"key":"2020021223021723500_REF15","doi-asserted-by":"crossref","unstructured":"Strasser A, Elefanty AG, Harris AW, Cory S. Progenitor tumours from E\u03bc-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J.1996;15: 3823-3834.","DOI":"10.1002\/j.1460-2075.1996.tb00756.x"},{"key":"2020021223021723500_REF16","unstructured":"Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol.1990; 137: 225-232."},{"key":"2020021223021723500_REF17","doi-asserted-by":"crossref","unstructured":"O'Reilly LA, Huang DCS, Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J.1996;15: 6979-6990.","DOI":"10.1002\/j.1460-2075.1996.tb01090.x"},{"key":"2020021223021723500_REF18","doi-asserted-by":"crossref","unstructured":"O'Reilly LA, Harris AW, Tarlinton DM, Corcoran LM, Strasser A. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J Immunol.1997; 159: 2301-2311.","DOI":"10.4049\/jimmunol.159.5.2301"},{"key":"2020021223021723500_REF19","doi-asserted-by":"crossref","unstructured":"Bouillet P, Metcalf D, Huang DCS, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 1999;286: 1735-1738.","DOI":"10.1126\/science.286.5445.1735"},{"key":"2020021223021723500_REF20","doi-asserted-by":"crossref","unstructured":"Wang Z, Raifu M, Howard M, et al. Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3\u2032 to 5\u2032 exonuclease activity. J Immunol Methods. 2000;233: 167-177.","DOI":"10.1016\/S0022-1759(99)00184-2"},{"key":"2020021223021723500_REF21","doi-asserted-by":"crossref","unstructured":"Rogerson BJ. Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes. Mol Immunol.1994;31: 83-98.","DOI":"10.1016\/0161-5890(94)90081-7"},{"key":"2020021223021723500_REF22","doi-asserted-by":"crossref","unstructured":"Strasser A, Harris AW, Cory S. The role of bcl-2 in lymphoid differentiation and transformation. Curr Top Microbiol Immunol.1992;182: 299-302.","DOI":"10.1007\/978-3-642-77633-5_37"},{"key":"2020021223021723500_REF23","unstructured":"Fredrickson TN, Harris AW. Atlas of Mouse Hematopathology. Amsterdam: Harwood Academic; 2000."},{"key":"2020021223021723500_REF24","doi-asserted-by":"crossref","unstructured":"Morse HC 3rd, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood. 2002;100: 246-258.","DOI":"10.1182\/blood.V100.1.246"},{"key":"2020021223021723500_REF25","doi-asserted-by":"crossref","unstructured":"Strasser A, Whittingham S, Vaux DL, et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A.1991;88: 8661-8665.","DOI":"10.1073\/pnas.88.19.8661"},{"key":"2020021223021723500_REF26","doi-asserted-by":"crossref","unstructured":"Strasser A, Harris AW, Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic selfcensorship. Cell. 1991;67: 889-899.","DOI":"10.1016\/0092-8674(91)90362-3"},{"key":"2020021223021723500_REF27","doi-asserted-by":"crossref","unstructured":"O'Reilly LA, Harris AW, Strasser A. Bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8- T cell progenitors. Int Immunol.1997;9: 1291-1301.","DOI":"10.1093\/intimm\/9.9.1291"},{"key":"2020021223021723500_REF28","doi-asserted-by":"crossref","unstructured":"Hildeman DA, Zhu Y, Mitchell TC, et al. Activated T cell death in vivo mediated by pro-apoptotic Bcl-2 family member, Bim. Immunity. 2002;16: 759-767.","DOI":"10.1016\/S1074-7613(02)00322-9"},{"key":"2020021223021723500_REF29","doi-asserted-by":"crossref","unstructured":"Bouillet P, Purton JF, Godfrey DI, et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 2002;415: 922-926.","DOI":"10.1038\/415922a"},{"key":"2020021223021723500_REF30","doi-asserted-by":"crossref","unstructured":"Poppema S, Kaleta J, Hugh J, Visser L. Neoplastic changes involving follicles: morphological, immunophenotypic and genetic diversity of lymphoproliferations derived from germinal center and mantle zone. Immunol Rev.1992;126: 163-178.","DOI":"10.1111\/j.1600-065X.1992.tb00636.x"},{"key":"2020021223021723500_REF31","doi-asserted-by":"crossref","unstructured":"Levy R, Levy S, Cleary ML, et al. Somatic mutation in human B-cell tumors. Immunol Rev.1987; 96: 43-58.","DOI":"10.1111\/j.1600-065X.1987.tb00508.x"},{"key":"2020021223021723500_REF32","doi-asserted-by":"crossref","unstructured":"Levy S, Mendel E, Kon S, Avnur Z, Levy R. Mutational hot spots in Ig V region genes of human follicular lymphomas. J Exp Med.1988;168: 475-489.","DOI":"10.1084\/jem.168.2.475"},{"key":"2020021223021723500_REF33","doi-asserted-by":"crossref","unstructured":"Dighiero G, Hart S, Lim A, Borche L, Levy R, Miller RA. Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood. 1991;78: 581-585.","DOI":"10.1182\/blood.V78.3.581.581"},{"key":"2020021223021723500_REF34","doi-asserted-by":"crossref","unstructured":"Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphomas. Blood. 1991;78: 1561-1568.","DOI":"10.1182\/blood.V78.6.1561.1561"},{"key":"2020021223021723500_REF35","doi-asserted-by":"crossref","unstructured":"Dighiero G. Autoantibody activity and V gene usage by B-cell malignancies. Leuk Lymphoma. 1992;8: 345-351.","DOI":"10.3109\/10428199209051013"},{"key":"2020021223021723500_REF36","doi-asserted-by":"crossref","unstructured":"Zelenetz AD, Chen TT, Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med.1992;176: 1137-1148.","DOI":"10.1084\/jem.176.4.1137"},{"key":"2020021223021723500_REF37","doi-asserted-by":"crossref","unstructured":"Kuo P, Alban A, Gebhard D, Diamond B. Overexpression of bcl-2 alters usage of mutational hot spots in germinal center B cells. Mol Immunol.1997;34: 1011-1018.","DOI":"10.1016\/S0161-5890(97)00117-X"},{"key":"2020021223021723500_REF38","doi-asserted-by":"crossref","unstructured":"Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 1998;280: 1750-1752.","DOI":"10.1126\/science.280.5370.1750"},{"key":"2020021223021723500_REF39","doi-asserted-by":"crossref","unstructured":"Muschen M, Re D, Jungnickel B, Diehl V, Rajewsky K, Kuppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med.2000;192: 1833-1840.","DOI":"10.1084\/jem.192.12.1833"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/6\/2276\/1696693\/zh800604002276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/6\/2276\/1696693\/zh800604002276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:33:54Z","timestamp":1682606034000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/6\/2276\/18400\/VavPBcl2-transgenic-mice-develop-follicular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,15]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-07-2469","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,15]]}}}